JP5843775B2 - 幹細胞を分化させるための重量オスモル濃度の操作法 - Google Patents

幹細胞を分化させるための重量オスモル濃度の操作法 Download PDF

Info

Publication number
JP5843775B2
JP5843775B2 JP2012533443A JP2012533443A JP5843775B2 JP 5843775 B2 JP5843775 B2 JP 5843775B2 JP 2012533443 A JP2012533443 A JP 2012533443A JP 2012533443 A JP2012533443 A JP 2012533443A JP 5843775 B2 JP5843775 B2 JP 5843775B2
Authority
JP
Japan
Prior art keywords
cells
mosm
ebs
osmolality
mtesr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2012533443A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013507135A (ja
JP2013507135A5 (https=
Inventor
アレクサンドラ エイ． ブラック
アレクサンドラ エイ． ブラック
シャロン エー． ルイス
シャロン エー． ルイス
Original Assignee
ステムセル テクノロジーズ インコーポレーティッド
ステムセル テクノロジーズ インコーポレーティッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ステムセル テクノロジーズ インコーポレーティッド, ステムセル テクノロジーズ インコーポレーティッド filed Critical ステムセル テクノロジーズ インコーポレーティッド
Publication of JP2013507135A publication Critical patent/JP2013507135A/ja
Publication of JP2013507135A5 publication Critical patent/JP2013507135A5/ja
Application granted granted Critical
Publication of JP5843775B2 publication Critical patent/JP5843775B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/60—Buffer, e.g. pH regulation, osmotic pressure
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
    • C12N2533/32—Polylysine, polyornithine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2012533443A 2009-10-13 2010-10-13 幹細胞を分化させるための重量オスモル濃度の操作法 Active JP5843775B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US25113009P 2009-10-13 2009-10-13
US61/251,130 2009-10-13
US35494710P 2010-06-15 2010-06-15
US61/354,947 2010-06-15
PCT/CA2010/001610 WO2011044684A1 (en) 2009-10-13 2010-10-13 Manipulation of osmolality for differentiating stem cells

Publications (3)

Publication Number Publication Date
JP2013507135A JP2013507135A (ja) 2013-03-04
JP2013507135A5 JP2013507135A5 (https=) 2013-11-21
JP5843775B2 true JP5843775B2 (ja) 2016-01-13

Family

ID=43855139

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012533443A Active JP5843775B2 (ja) 2009-10-13 2010-10-13 幹細胞を分化させるための重量オスモル濃度の操作法

Country Status (7)

Country Link
US (1) US10913929B2 (https=)
EP (1) EP2488631B1 (https=)
JP (1) JP5843775B2 (https=)
CN (1) CN102762718B (https=)
AU (1) AU2010306377B2 (https=)
IL (1) IL218996A (https=)
WO (1) WO2011044684A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9708582B2 (en) * 2009-10-13 2017-07-18 Stemcell Technologies Inc. Method of differentiating stem cells
US9149026B2 (en) 2010-06-11 2015-10-06 Regeneron Pharmaceuticals, Inc. Production of fertile XY animals from XY ES cells
CN102851314A (zh) * 2011-07-01 2013-01-02 中国科学院上海药物研究所 诱导性多能干细胞的制备方法和用于制备诱导性多能干细胞的培养基
PT2773748T (pt) * 2011-11-04 2020-03-26 Memorial Sloan Kettering Cancer Center Neurónios dopaminérgicos (da) do mesencéfalo para enxerto
WO2013163455A2 (en) * 2012-04-25 2013-10-31 The Regents Of The University Of California A drug screening platform for rett syndrome
WO2014143383A1 (en) 2013-03-13 2014-09-18 Agilent Technologies, Inc. Transposome tethered to a gene delivery vehicle
WO2014200339A1 (en) * 2013-06-11 2014-12-18 Pluriomics B.V. Culture medium compositions for maturating cardiomyocytes derived from pluripotent mammalian stem cells
US9546384B2 (en) 2013-12-11 2017-01-17 Regeneron Pharmaceuticals, Inc. Methods and compositions for the targeted modification of a mouse genome
KR102386101B1 (ko) 2014-06-26 2022-04-14 리제너론 파마슈티칼스 인코포레이티드 표적화된 유전자 변형을 위한 방법 및 그 조성물, 및 사용 방법
CN104293730B (zh) * 2014-09-23 2017-07-28 云南中科灵长类生物医学重点实验室 多能干细胞体外定向分化为心肌细胞的方法
DK3207124T3 (da) * 2014-10-15 2019-08-12 Regeneron Pharma Fremgangsmåder og sammensætninger til generering eller bevaring af pluripotente celler
US9730975B2 (en) 2014-11-25 2017-08-15 The Penn State Research Foundation Chemical reprogramming of human glial cells into neurons for brain and spinal cord repair
CN104782583B (zh) * 2015-04-29 2017-04-12 中国农业科学院兰州兽医研究所 一种棘球蚴体外三维培养模型及其应用
SG10201913789VA (en) 2015-09-17 2020-03-30 Regeneron Pharma Selection of pluripotent cells for production of fertile xy female mice
HUE067905T2 (hu) * 2015-11-12 2024-11-28 Hoffmann La Roche Oligonukleotidok paternális UBE3A expresszió indukálására
CN105886457A (zh) * 2016-05-16 2016-08-24 中国人民解放军军事医学科学院野战输血研究所 诱导干细胞分化成外胚层祖细胞的方法
US11180733B2 (en) 2016-07-04 2021-11-23 Agency For Science, Technology And Research Method of generating mesenchymal stem cells and uses thereof
KR101810012B1 (ko) 2017-10-23 2018-01-18 차의과학대학교 산학협력단 히스톤 데아세틸라제 저해제 및 골 형성 단백질 경로 차단제를 이용한 인간-유래의 체세포로부터 역분화 만능 줄기세포의 제조방법
KR102167257B1 (ko) * 2019-05-28 2020-10-19 부산대학교 산학협력단 토마티딘 처리를 통한 줄기세포의 성숙화된 심근세포로의 분화유도 촉진 방법
CN114269900B (zh) * 2019-08-20 2025-01-14 千纸鹤治疗公司 心肌细胞的富集方法
KR20220129584A (ko) * 2020-01-14 2022-09-23 아지노모토 가부시키가이샤 삼투압 저감 배지
MX2022011245A (es) 2020-03-11 2023-01-11 Bit Bio Ltd Método de generación de células hepáticas.
CN114621920B (zh) * 2022-02-22 2023-09-05 中国医学科学院血液病医院(中国医学科学院血液学研究所) 一种由造血干祖细胞向nk细胞分化的方法及培养基

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5221537A (en) * 1988-09-02 1993-06-22 Gerald Hecht Tissue irrigating solutions
US7439064B2 (en) 2000-03-09 2008-10-21 Wicell Research Institute, Inc. Cultivation of human embryonic stem cells in the absence of feeder cells or without conditioned medium
AU2001283504A1 (en) * 2000-07-27 2002-02-13 The Mclean Hospital Corporation Cell implantation therapy for neurological diseases or disorders
US20060040385A1 (en) * 2002-12-05 2006-02-23 Technion Research & Development Foundation Ltd. Cultured human pancreatic islets, and uses thereof
US20040224401A1 (en) * 2003-03-28 2004-11-11 Ludwig Tenneille E. Physiochemical culture conditions for embryonic stem cells
WO2007050043A2 (en) 2005-10-24 2007-05-03 Agency For Science, Technology And Research Methods of specifying mesodermal, endodermal and mesoendodermal cell fates
GB0623635D0 (en) 2006-11-27 2007-01-03 Stem Cell Sciences Uk Ltd Pluripotent cell growth media
EP2115125B1 (en) * 2007-01-03 2016-09-07 NeoStem Oncology, LLC Stem cell growth media and methods of making and using same
US20090068741A1 (en) 2007-01-17 2009-03-12 Invitrogen Corporation Methods and Compositions for Improving the Health of Cells in Culture
FI20075417A0 (fi) 2007-06-05 2007-06-05 Marjo-Riitta Suuronen Koostumuksia ja menetelmiä alkion kantasolujen kasvatukseen
HRP20180738T1 (hr) 2008-09-15 2018-06-15 F. Hoffmann - La Roche Ag Pripravci i postupci za regulaciju stanične osmolarnosti

Also Published As

Publication number Publication date
CN102762718B (zh) 2015-06-17
AU2010306377A1 (en) 2012-05-10
CN102762718A (zh) 2012-10-31
JP2013507135A (ja) 2013-03-04
US20110086379A1 (en) 2011-04-14
US10913929B2 (en) 2021-02-09
EP2488631B1 (en) 2020-01-08
EP2488631A1 (en) 2012-08-22
AU2010306377B2 (en) 2015-01-22
WO2011044684A1 (en) 2011-04-21
EP2488631A4 (en) 2013-06-26
IL218996A (en) 2017-04-30
IL218996A0 (en) 2012-06-28

Similar Documents

Publication Publication Date Title
JP5843775B2 (ja) 幹細胞を分化させるための重量オスモル濃度の操作法
US9708582B2 (en) Method of differentiating stem cells
JP5721111B2 (ja) 幹細胞の培地及び培養方法
JP6013196B2 (ja) 多能性幹細胞から誘導した細胞を精製するための方法
Chaddah et al. Clonal neural stem cells from human embryonic stem cell colonies
CN101962629B (zh) 肝脏前体细胞及其制备方法与应用
WO2011028524A1 (en) Substantially pure human retinal progenitor, forebrain progenitor, and retinal pigment epithelium cell cultures and methods of making the same
JP2005502356A (ja) 治療のための腸内幹細胞の分離、培養および分化方法
JP6860539B2 (ja) 幹細胞および幹細胞に由来する細胞を単離するための、接着シグネチャーベースの方法
Kumar et al. Generation of an expandable intermediate mesoderm restricted progenitor cell line from human pluripotent stem cells
A. Cohen et al. Neural differentiation of human ES cells
WO2018124605A1 (ko) 기형종 형성이 억제된 전분화능 줄기세포 유래 신경 전구체구의 제조 방법
CN101962628B (zh) 肝脏内胚层细胞及其制备和纯化方法
CN110392735A (zh) 胰腺祖细胞的维持和扩增
Klimanskaya Retinal pigment epithelium
Li et al. Engraftable neural crest stem cells derived from cynomolgus monkey embryonic stem cells
Major et al. Derivation of telencephalic oligodendrocyte progenitors from human pluripotent stem cells
US20070020608A1 (en) Method for the generation of neural progenitor cells
Sue O’Shea Neural differentiation of embryonic stem cells
Sharp et al. Derivation of oligodendrocyte progenitor cells from human embryonic stem cells
Kaur et al. Neural stem cell assays
Hatch et al. Oligodendrocyte Differentiation from Human Embryonic Stem Cells
WO2023054325A1 (ja) 細胞表面マーカーを用いた下垂体細胞および視床下部細胞の分離法
Schmandt et al. Lineage selection and transplantation of mouse ES cell-derived neural precursors
Moore Differentiation of human and murine embryonic stem cells: Studies on the combined roles of adhesion molecules and growth factors

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20131001

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20131001

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20141217

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150309

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150427

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20150427

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20150529

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150819

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150930

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151001

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20151026

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20151117

R150 Certificate of patent or registration of utility model

Ref document number: 5843775

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250